OrthoPediatrics Corp (KIDS)
22.93
+0.24
(+1.06%)
USD |
NASDAQ |
Nov 15, 16:00
22.94
+0.01
(+0.04%)
After-Hours: 20:00
OrthoPediatrics Research and Development Expense (TTM): 10.34M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.34M |
| June 30, 2024 | 10.32M |
| March 31, 2024 | 10.75M |
| December 31, 2023 | 10.20M |
| September 30, 2023 | 10.01M |
| June 30, 2023 | 9.652M |
| March 31, 2023 | 8.433M |
| December 31, 2022 | 8.014M |
| September 30, 2022 | 7.588M |
| June 30, 2022 | 6.684M |
| March 31, 2022 | 6.262M |
| December 31, 2021 | 5.543M |
| September 30, 2021 | 5.985M |
| June 30, 2021 | 5.76M |
| March 31, 2021 | 5.316M |
| December 31, 2020 | 5.273M |
| September 30, 2020 | 5.128M |
| Date | Value |
|---|---|
| June 30, 2020 | 5.447M |
| March 31, 2020 | 5.80M |
| December 31, 2019 | 5.748M |
| September 30, 2019 | 5.12M |
| June 30, 2019 | 4.846M |
| March 31, 2019 | 4.727M |
| December 31, 2018 | 4.732M |
| September 30, 2018 | 4.396M |
| June 30, 2018 | 4.401M |
| March 31, 2018 | 3.954M |
| December 31, 2017 | 3.423M |
| September 30, 2017 | 3.106M |
| June 30, 2017 | 2.48M |
| March 31, 2017 | 2.401M |
| December 31, 2016 | 2.221M |
| September 30, 2016 | 2.076M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
5.128M
Minimum
Sep 2020
10.75M
Maximum
Mar 2024
7.412M
Average
6.473M
Median
Research and Development Expense (TTM) Benchmarks
| The Cooper Companies Inc | 154.10M |
| Staar Surgical Co | 52.80M |
| NexGel Inc | 0.097M |
| Innovative Eyewear Inc | 0.7866M |
| Perspective Therapeutics Inc | 28.53M |